These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5108271)

  • 1. [The influence of orally applied iproveratril (Verapamil) on coronayy blood flow, oxygen consumption and carbon dioxide formation in the human heart].
    Rudolph W; Kriener J; Meister W
    Arzneimittelforschung; 1971 Apr; 21(4):462-5. PubMed ID: 5108271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oxygen uptake and carbon dioxide release by the human heart under the influence of iproveratril (Verapamil)].
    Rudolph W; Meister W; Kriener J
    Arzneimittelforschung; 1971 Apr; 21(4):458-62. PubMed ID: 5108140
    [No Abstract]   [Full Text] [Related]  

  • 3. [Substrate metabolism of the human heart under the influence of iproveratril (Verapamil)].
    Rudolph W; Meister W; Kriener J
    Arzneimittelforschung; 1971 Apr; 21(4):449-58. PubMed ID: 5108139
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
    [No Abstract]   [Full Text] [Related]  

  • 5. [Parallel influence of isometric tension development and O2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproteranol and organic Ca antagonists (iproveratril, D 600, prenylamine)].
    Byon KY; Fleckenstein A
    Pflugers Arch; 1969; 312(1):R8-9. PubMed ID: 5390309
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
    Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effects of various coronary dilators on oxygen consumption, heart frequency and blood pressure in a standardized charge on the ergometer].
    Roskamm H; Fröhlich GJ; Reindell H
    Arzneimittelforschung; 1966 Jul; 16(7):835-41. PubMed ID: 4967662
    [No Abstract]   [Full Text] [Related]  

  • 8. Some effects of iproveratril (Isoptin) on the cardiovascular system.
    Nayler WG; McInnes I; Swann JB; Price JM; Carson V; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Jun; 161(2):247-61. PubMed ID: 5650138
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)].
    Fleckenstein A; Tritthart H; Fleckenstein B; Herbst A; Grün G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):227-8. PubMed ID: 4242380
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of iproveratril and nitroglycerin in the heart and coronary circulation of dogs.
    Ross G; Jorgensen C
    Am Heart J; 1968 Jul; 76(1):74-8. PubMed ID: 4968958
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coronary blood flow and oxygen consumption of human heart under the effect of hexobendine].
    Rudolph W; Marko I; Baubkus H; Müller-Seydlitz P; Gadomski M; Posse P; Gulde M; Jetschgo G
    Arzneimittelforschung; 1970 May; 20(5):637-47. PubMed ID: 5468053
    [No Abstract]   [Full Text] [Related]  

  • 12. On the cardiac adrenergic blocking action of iproveratril in normal and coronary-ligated dogs.
    Melville KI; Garvey HL; Shister HE
    Rev Can Biol; 1968 Sep; 27(3):225-35. PubMed ID: 5702439
    [No Abstract]   [Full Text] [Related]  

  • 13. [Control of myocardial metabolism by verapamil. Sites of action and therapeutic effects].
    Fleckenstein A
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1317+. PubMed ID: 5536556
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
    Bosse JA; Schaum E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):221-2. PubMed ID: 4390696
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].
    Fleckenstein A; Tritthart H; Flackenstein B; Herbst A; Grün G
    Pflugers Arch; 1969; 307(2):R25. PubMed ID: 5814829
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of verapamil on coronary blood flow, oxygen utilisation and carbon dioxide production in human heart].
    Rudolph W; Kriener J; Meister W
    Klin Wochenschr; 1971 Sep; 49(17):982-8. PubMed ID: 5093463
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sympatholytic ("antisympathotonic") substances].
    Kruger K
    Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
    [No Abstract]   [Full Text] [Related]  

  • 18. [Limitation of the disappearance of energy-rich phosphate compounds in the hyperactive atrial and ventricular myocardium by divalent Ca-antagonistic inhibitors of electromechanical coupling (iprovdratril, D 600, prenylamine)].
    Doring HJ; Leder O; Jaedicke W; Reindell A; Fleckenstein A
    Pflugers Arch; 1969; 312(1):R7-8. PubMed ID: 5390299
    [No Abstract]   [Full Text] [Related]  

  • 19. The actions of verapamil on experimental arrhythmias.
    Rodrigues-Pereira E; Viana AP
    Arzneimittelforschung; 1968 Feb; 18(2):175-9. PubMed ID: 5695375
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the influence of beta-receptor blocking agents, iproveratril, quinidine and reserpine on the effect of k-strophanthin in the guinea pig heart].
    Fratz R; Greeff K; Wagner J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):196-206. PubMed ID: 4233000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.